Capital Research Global Investors
NXGN

Capital Research Global Investors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Capital Research Global Investors’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,760,000
Closed -$28.5M – 431
2023
Q2 		$28.5M Hold
1,760,000
– – 0.01% 353
2023
Q1 		$30.6M Hold
1,760,000
– – 0.01% 355
2022
Q4 		$33.1M Buy
1,760,000
+1,353,700
+333% +$26.1M 0.01% 357
2022
Q3 		$7.19M Buy
+406,300
New +$7.05M ﹤0.01% 399

Other funds holding NXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Capital Research Global Investors's NXGN Position: Q3 2023 in Review

Capital Research Global Investors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 1,760,000 shares — an estimated $28.5M sold.

Capital Research Global Investors first reported a position in NXGN in Q3 2022 and held it in 4 quarters. The position peaked at $33.1M in Q4 2022. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • Capital Research Global Investors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Capital Research Global Investors sold 1,760,000 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $28.5M.
  • Capital Research Global Investors first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Capital Research Global Investors's NextGen Healthcare, Inc. Common Stock position peaked at $33.1M in Q4 2022.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Capital Research Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.